Important development: FEMTECH subsidiary OCON Healthcare of the Merchavia Investments Group inked an exclusive deal with BioGenuine

The Israeli FEMTECH company OCON Healthcare, part of the Merchavia Holdings and Investments (TASE: MRHL) group of companies, has announced that it has reached a legally binding agreement with BioGenuine, a Chinese pharmaceutical company specialising in women's health. BioGenuine will start ma...

Wellster Acquires 17.5 million Euros for the Launch of Femtech

A Swiss healthcare start-up, Wellster, has announced that it raised 17.5 million euros in Series B funding only 6 months after it had acquired 35 million euros in the first round.

Claret Capital and VC Mangrove Capital Partners have led the latest round of funding. This cemented the pos...